Model diagnostics for multi-state models

Statistical Methods in Medical Research

Volumn 19, Issue 6, 2010, Pages 621-651

  Titman, Andrew C ^a   Sharples, Linda D ^b  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; PROBABILITY; STATISTICAL ANALYSIS; STATISTICAL MODEL; VALIDITY;

BIOSTATISTICS; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DISEASE PROGRESSION; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MARKOV CHAINS; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; STATISTICS, NONPARAMETRIC; VASCULAR DISEASES;

EID: 78649932181     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/0962280209105541     Document Type: Article

References (56)

1. Gentleman RC, Lawless JF, Lindsey JC, Yan P. Multi-state Markov models for analysing incomplete disease data with illustrations for HIV disease. Statistics in Medicine 1994 ; 13: 805-21.
2. Mathieu E., Loup P., Dellamonica P., Daures JP Markov modelling of immunological and virological states in HIV-1 infected patients. Biometrical Journal 2005 ; 47: 834-46.
3. Satten GA, Longini IM Markov chains with measurement error: estimating the 'true' course of a marker of the progression of Human Immunodeficiency Virus disease. Applied Statistics 1996 ; 45: 265-309.
4. Bureau A., Shiboski S., Hughes JP Applications of continuous time hidden Markov models to the study of misclassified disease outcomes. Statistics in Medicine 2003 ; 22: 441-62.
5. Kang M., Lagakos SW Statistical methods for panel data from a semi-Markov process, with application to HPV. Biostatistics 2007 ; 8: 252-64.
6. Cook RJ, Yi GY, Lee K. A conditional Markov model for clustered progressive multistate processes under incomplete observation. Biometrics 2004 ; 60: 436-43.
7. Kosorok MR, Chao WH The analysis of longitudinal ordinal response data in continuous time. Journal of the American Statistical Association 1996 ; 91: 807-17.
8. Jackson CH msm: Multi-state Markov and hidden Markov models in continuous time. R package version 0.8, 2008.
9. Titman AC, Sharples LD A general goodness-of-fit test for Markov and hidden Markov models. Statistics in Medicine 2008 ; 27: 2177-95.
10. Cox DR, Miller HD The theory of stochastic processes. Chapman and Hall, London ; 1965.
11. Klotz JH, Sharples LD Estimation for a Markov heart transplant model. Journal of the Royal Statistical Society. Series D 1994 ; 43: 431-38.
12. Kalbfleisch JD, Lawless JF The analysis of panel data under a Markov assumption. Journal of the American Statistical Association 1985 ; 80: 863-71.
13. Alioum A., Commenges D. MKVPCI: A computer program for Markov models with piecewise constant intensities and covariates. Computer Methods and Programs in Biomedicine 2001 ; 64: 109-19.
14. Bureau A., Hughes JP An S-Plus implementation of hidden Markov models in continuous time. Journal of Computational and Graphical Statistics 2000 ; 9: 621-32.
15. Jackson CH, Sharples LD Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients. Statistics in Medicine 2002 ; 21: 113-28.
16. Siannis F., Farewell VT, Head J. A multi-state model for joint modelling of terminal and non-terminal events with application to Whitehall II. Statistics in Medicine 2007 ; 26: 426-42.
17. Muller H-G., Wang J-L. Hazard rate estimation under random censoring with varying kernels and bandwidths. Biometrics 1994 ; 50: 61-76.
18. Efron B., Tibshirani RJ An introduction to the bootstrap. Chapman and Hall: New York, 1993.
19. Gruger J., Kay R., Schumacher M. The validity of inferences based on incomplete observations in disease state models. Biometrics 1991 ; 47: 595-605.
20. Peto R. Experimental survival curves for interval-censored data. Applied Statistics 1973 ; 22: 86-91.
21. Turnbull BW The empirical distribution function with arbitrarily grouped, censored and truncated data. Journal of the Royal Statistical Society. Series B 1976 ; 38: 290-95.
22. Frydman H. A nonparametric estimation procedure for a periodically observed three-state Markov process, with application to AIDS. Journal of the Royal Statistical Society: Series B. 1992 ; 54: 853-66.
23. Frydman H. Nonparametric estimation of a Markov 'illness-death' process from interval-censored observations, with application to diabetes survival data. Biometrika 1995 ; 82: 773-89.
24. Gaüzère F. Approche non-paramétrique pour un modèle 3 états avec censures par intervalles - application à la dépendance. PhD thesis, Université Victor Segalen Bordeaux 2, 2000.
25. Frydman H., Szarek M. Nonparametric estimation in a Markov "illness-death" process from interval-censored observations with missing intermediate transition status. Biometrics 2009 ; 65: 143-151
26. Satten GA, Sternberg MR Fitting semi-Markov models to interval-censored data with unknown initiation times Biometrics 1999 ; 55: 507-13.
27. Sternberg MR, Satten GA Discrete-time nonparametric estimation for semi-Markov models of chain-of-events data subject to interval censoring and truncation. Biometrics 1999 ; 55: 514-22.
28. Alioum A., Commenges D. A proportional hazards model for arbitrarily censored and truncated data. Biometrics 1996 ; 52: 512-24.
29. Sun J. Variance estimation of a survival function for interval-censored survival data. Statistics in Medicine 2001, 20: 1249-57.
30. Commenges D. Inference for multi-state models from interval-censored data. Statistical Methods in Medical Research 2002 ; 11: 167-82.
31. Joly P., Commenges D. A penalized likelihood approach for a progressive three-state model with censored and truncated data: application to AIDS. Biometrics 1999 ; 55: 887-90.
32. Joly P., Commenges D., Helmer C., Letenneur L. A penalized likelihood approach for an illness-death model with interval-censored data: application to age-specific incidence of dementia. Biostatistics 2002 ; 3: 433-43.
33. Commenges D., Joly P., Gégout-Petit A., Liquet B. Choice between semi-parametric estimators of Markov and non-Markov multi-state models from coarsened observations. Scandinavian Journal of Statistics 2007 ; 34: 33-52.
34. Chen P-L., Bernard EJ, Sen PK A Markov chain model used in analyzing disease history applied to a stroke study. Journal of Applied Statistics 1999 ; 4: 413-22.
35. Lindsey JC, Ryan LM A three-state multiplicative model for rodent tumorigenicity experiments. Applied Statistics 1993 ; 42: 283-300.
36. Cook RJ, Zeng L., Lee K-A. A multistate model for bivariate interval-censored failure time data. Biometrics 2008 ; 64: 1100-9.
37. Bowman AW, Azzalini A. Applied smoothing techniques for data analysis: the Kernel approach with S-plus illustrations. Oxford University Press, Oxford, 1997.
38. Bowman AW, Azzalini A.R. package sm: Nonparametric smoothing methods (version 2.2) 2007.
39. de Stavola B.L. Testing departures from time homogeneity in multistate Markov processes. Applied Statistics 1988 ; 37: 242-50.
40. Hougaard P. Analysis of multivariate survival data Springer, Heidelberg; 2000.
41. Aguirre-Hernandez R., Farewell VT A Pearson-type goodness-of-fit test for stationary and time-continuous Markov regression models. Statistics in Medicine 2002 ; 21: 1899-911.
42. Titman AC Computation of the asymptotic null distribution of goodness-of-fit tests for multi-state models. Technical Report 2008. Available at http://eprints.lancs.ac.uk/23532/
43. Lawless JF Statistical models and methods for lifetime data. Wiley, New York, 1982.
44. Perez-Ocon R., Ruiz-Castro JE, Gamiz-Perez ML A piecewise Markov process for analysing survival from breast cancer in different risk groups. Statistics in Medicine 2001 ; 20: 109-22.
45. Castelli C., Combescure C., Foucher Y., Daures JP Cost-effectiveness analysis in colorectal cancer using a semi-Markov model. Statistics in Medicine 2007 ; 26: 5557-71.
46. Satten GA Estimating the extent of tracking in interval-censored chain-of-events data. Biometrics 1999 ; 55: 1228-31.
47. Self SG, Liang K-Y. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions. Journal of the American Statistical Association 1987 ; 82: 605-10.
48. Lancaster T., Nickell S. The analysis of re-employment probabilities for the unemployed. Journal of the Royal Statistical Society: Series A 1980 ; 143: 141-65.
49. Kay R. A Markov model for analysing cancer markers and diseases states in survival studies. Biometrics 1986 ; 42: 855-65.
50. Omar RZ, Stallard N., Whitehead J. A parametric multistate model for the analysis of carcinogenicity experiments. Lifetime Data Analysis 1995 ; 1: 327-46.
51. Hubbard RA, Inoue LYT, Fann JR Modeling nonhomogeneous Markov processes via time transformation. Biometrics 2008 ; 64: 843-50.
52. Hsieh H-J., Chen TH-H, Chang S-H. Assessing chronic disease progression using non-homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan. Statistics in Medicine 2002 ; 21: 3369-82.
53. Hui-Min W., Ming-Fang Y., Chen T. H-H. SAS macro program for non-homogeneous Markov process in modeling multi-state disease progression. Computer Methods and Programs in Biomedicine 2004 ; 75: 95-105.
54. Foucher Y., Giral M., Soulillou J-P., Daures J-P. A flexible semi-Markov model for interval-censored data and goodness-of-fit testing. Statistical Methods in Medical Research 2008 ; Online First, DOI:10.1177/0962280208093889.
55. Crespi CM, Cumberland WG, Blower S. A queuing model for chronic recurrent conditions under panel observation. Biometrics 2005 ; 61: 193-98.
56. Lystig TC, Hughes JP Exact computation of the observed information matrix for hidden Markov models. Journal of Computational and Graphical Statistics 2002 ; 11: 678-89.